Literature DB >> 10502319

11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome.

M Nishiyama1, Y Arai, Y Tsunematsu, H Kobayashi, K Asami, M Yabe, S Kato, M Oda, H Eguchi, M Ohki, Y Kaneko.   

Abstract

In a survey of childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) in Japan, we found 11p15 translocations in 5 (6%) of 81 children with t-AML/MDS. t(11;17)(p15;q21), t(11;12)(p15;q13), t(7;11)(p15;p15), inv(11)(p15q22), and add(11)(p15) were each found in one patient. Southern blotting and/or RT-PCR analyses revealed rearrangements of the NUP98 gene in tumor samples of all five patients. Rearrangements of DDX10 were detected in t-AML/MDS cells with inv(11), and rearrangements of HOXA9 were detected in t-AML cells with t(7;11). The 17q21 breakpoint of t(11;17) and the 12q13 breakpoint of t(11;12)(p15;q13) coincided with the loci of the HOXB and HOXC gene families, respectively. Therefore, it is reasonable to speculate that one of the HOXB genes and one of the HOXC genes were fused to NUP98 by t(11;17) and t(11;12), respectively, in t-AML/MDS cells. We propose that NUP98 may be a target gene for t-AML/MDS, and that t-AML/MDS with a fusion of NUP98 and HOX or DDX10 genes may be more frequent in children than in patients of other age groups. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502319

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  19 in total

1.  A novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and development.

Authors:  V E Gould; N Martinez; A Orucevic; J Schneider; A Alonso
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Imaging hematopoietic precursor division in real time.

Authors:  Mingfu Wu; Hyog Young Kwon; Frederique Rattis; Jordan Blum; Chen Zhao; Rina Ashkenazi; Trachette L Jackson; Nicholas Gaiano; Tim Oliver; Tannishtha Reya
Journal:  Cell Stem Cell       Date:  2007-11       Impact factor: 24.633

3.  NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.

Authors:  E Kroon; U Thorsteinsdottir; N Mayotte; T Nakamura; G Sauvageau
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

4.  Nationwide survey of therapy-related leukemia in childhood in Japan.

Authors:  Toshihiko Imamura; Takashi Taga; Masatoshi Takagi; Hirohide Kawasaki; Katsuyoshi Koh; Tomohiko Taki; Souichi Adachi; Atsushi Manabe; Yasushi Ishida
Journal:  Int J Hematol       Date:  2018-03-24       Impact factor: 2.490

5.  Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling.

Authors:  Julia Starkova; Sharvari Gadgil; Yi Hua Qiu; Nianxiang Zhang; Ivana Hermanova; Steven M Kornblau; Harry A Drabkin
Journal:  Haematologica       Date:  2011-02-28       Impact factor: 9.941

Review 6.  Molecular pathogenesis of MDS.

Authors:  Hisamaru Hirai
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  Acute monocytic leukaemia with t(11; 12) (p15; q13) chromosomal changes: A case report and literature review.

Authors:  Jiasheng Hu; Xiuli Hong; Zhe Li; Quanyi Lu
Journal:  Oncol Lett       Date:  2015-07-20       Impact factor: 2.967

Review 8.  Chromosome and molecular abnormalities in myelodysplastic syndromes.

Authors:  Pierre Fenaux
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

9.  A case of acute myeloid leukemia with t(7;11)(p15;p15) mimicking myeloid crisis of chronic myelogenous leukemia.

Authors:  Keiki Kawakami; Setsuko Miyanishi; Kazuhiho Nishii; Eiji Usui; Tetsuya Murata; Isaku Shinsato; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

Review 10.  Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Authors:  Nicole L Michmerhuizen; Jeffery M Klco; Charles G Mullighan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.